Ovarian cancer cells utilize extracellular vesicles to deliver arginase ARG1 to immune cells, which inhibits the proliferation of CD4+ and CD8+ T cells by affecting their arginine metabolism, thereby suppressing antitumor immune responses [27]. This evidence concerns the gene CD8A and ovarian carcinoma.